文献速递流行病学与生物统计新药、器械与细胞基因治疗研发

急性高钾血症的诊断与管理

Diagnosis and management of acute hyperkalaemia.
PubMed 文献 · BMJ · 2026-08-21

高钾血症是常见且可能危及生命的电解质异常,与恶性心律失常和心脏骤停相关,在急慢性医疗场景中均常见。本文综述其流行病学、病理生理、危险因素与诊断要点,并回顾急性及慢性管理的循证方法,关注特殊人群与高风险临床情境。

要点

  • 高钾血症与恶性心律失常和心脏骤停相关,属潜在危及生命的电解质异常。
  • 慢性肾病、心衰、糖尿病及使用损害肾排钾药物者风险更高。
  • 诊断与管理策略存在较大差异,新钾结合剂的出现推动管理更新。

核心结论

  • 高钾血症常见且可危及生命,需基于最新证据更新诊断与管理策略。

研究设计与样本

  • 本文为 state of the art review,汇总高钾血症流行病学、病理生理、诊断与管理的当代证据。

主要发现

  • 高钾血症在急慢性医疗场景中常见,对慢性肾病、心衰、糖尿病及使用损害肾排钾药物者影响尤甚。
  • 常见病因包括肾排钾受损(慢性肾病或药物抑制肾素-血管紧张素-醛固酮系统)及跨细胞钾转移。
  • 跨细胞钾转移可由代谢性酸中毒、组织分解、胰岛素缺乏或高渗状态引起。
  • 不同临床场景在定义、风险分层与治疗方式上存在明显差异。

临床怎么用

  • 应识别高危患者与常见病因,并结合不同临床场景的定义与风险分层进行诊治。
  • 管理需关注急性和慢性两个阶段,并重视特殊人群与高风险临床情境。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hyperkalaemia is a common and potentially life threatening electrolyte abnormality because of its association with malignant cardiac arrhythmias and sudden cardiac arrest. This condition is frequently encountered across acute and chronic care settings and disproportionately affects patients with comorbid conditions like chronic kidney disease, heart failure, diabetes mellitus, and those receiving drugs that impair renal potassium excretion. The most frequent causes of hyperkalaemia include impaired renal potassium elimination, from chronic kidney disease or pharmacological inhibition of the renin-angiotensin-aldosterone system, and transcellular potassium shifts resulting from metabolic acidosis, tissue breakdown, insulin deficiency, or hypertonic states. Despite its prevalence and clinical importance, substantial variability exists in the approach to diagnosis and management of hyperkalaemia, reflecting differences in definitions, risk stratification, and therapeutic approaches across clinical settings. Management strategies have evolved in recent years with improved understanding of potassium physiology and the availability of newer potassium binding agents, necessitating an updated synthesis of the evidence. In this state of the art review, we summarise contemporary data on the epidemiology and pathophysiology of hyperkalaemia, identify key risk factors and diagnostic considerations, and review evidence based approaches to acute and chronic management, with particular attention to special populations and high risk clinical scenarios.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Rech MA, Zimmerman DE, Ray L, et al. Diagnosis and management of acute hyperkalaemia. BMJ. 2026. PMID: 42629001. doi:10.1136/bmj-2026-100287

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。